Lectures & Slides

The following slides are kindly made available by their authors

Lectures not listed here but in the programme are not available for download.
If your presentation should or should not be listed there, please contact us.

Please download all available slides here:   PDF 
Opens in a new window.

www.cytel.com 


Group Sequential and Adaptive Design for Confirmatory Trials using East



Regulatory Topics and Guidelines
  • EMA Guidance Documents: Overview of Recent Developments (T. Lang)
  • The Changing Environment for Drug Development and Drug Licensing in Europe after ICH (J. Röhmel)
Multiple Comparisons
  • Statistical Criteria for Components of Primary Composite Endpoint to Support Benefit-Risk Assessment at an Interim Analysis Using Blinded Data (J. Brumm)
  • A Parametric Rüger Test and Diagnostic Trials (R. Ristl, C. Gartner, T. Lang, M. Posch)
Recent Advances in Time-to-Event Models
  • Practical Implications of Competing Risk Models – How to Interpret the Results to Clinicians (M. Smastuen)
  • Understanding Treatment Mechanisms in Clinical Survival Trials – A Causal Approach (S. Strohmaier, T. Pedersen, T. Lange, Ø. Borgan, O.O. Aalen)
Health Technology Assessment (HTA)
  • Biometrical Issues in Health Technology Assessment (R. Bender)
  • Designing Drug Development to Optimize HTA Submissions (K. Facey)
  • Statistics in Health Technology Assessment: Issues and Challenges (Y. Castro)
Multiregional Trials
  • Multiregional Clinical Trials: Introduction to Basic Features and Discussion of Special Issues (B. Jones, P. Gallo)
  • Heterogeneity in Multiregional Studies (J. Röhmel)
Multistate Models – Cure Models
  • Cure Models Based on Univariate and Bivariate Random Effects (A. Wienke)
  • A New Approach Based on Pseudo-Values for Assessing the Effect of a Binary Time-Dependent Covariate on Patient Survival (U. Pötschger, H. Heinzl, A. Attarbaschi, M. Minkov, M. Mittlböck)
  • Multistate Models with Multiple Time Scales (B. Carstensen, S. Iacobelli)
Flexible and Adaptive Designs
  • Treatment Selection in Multi-Arm, Multi-Stage Clinical Trials (T. Jaki, D. Magirr, N. Stallard)
  • Case Studies for Adaptive Treatment Arm Selection and Population Enrichment Designs (G. Wassmer)
  • Type I Error Rate Control in Adaptive Clinical Trials with blinded interim Analysis (M. Posch, M. Malina)
  • Population Enrichment Designs for Molecularly Targeted Therapies in Oncology (C. Mehta)
Analysis of Registries and Large Databases
  • Analysis of Large Registry-Based Study of Prescription Drugs and Road Traffic Crashes (M. Avalos, L. Orriols)
  • Mammography Screening and Cancer Registration in Tyrol/Austria (W. Oberaigner)
  • Observational Studies, Matching and Propensity Scores: An Application to Colorectal Cancer Data (J. Hinde, C. Dooley)
  • The Use of Propensity Scores in Observational Trials (J. Alsop)
Growth Curves: GAMLSS, SITAR and Austrian Kids
  • Development of New Austrian Height and Weight References (A. Gleiss, G. Häusler, M. Schemper)
  • SITAR Growth Curve Analysis to Evaluate Interventions and Life Course Outcomes (T. Cole)
Statistics in Drug Development
  • Developing Drugs for Reimbursement – Current and Future Challenges for Statisticians (M. Scott)
Risk Prediction
  • Shrinkage of Regression Coefficients: Old Concepts and New Ideas (D. Dunkler, G. Heinze)
  • On Criteria for Evaluating Risk Prediction Models for Public Health Applications (R. Pfeiffer)
  • Changes of Body Mass Index in Relation to Mortality: Results of a Cohort of 42,099 Adults (G. Nagel, K. Rapp, H. Ulmer, H. Concin, J. Klenk)
  • Evaluating Disease Predictors with Repeated Measurements: A Longitudinal Study of Alzheimer's Disease (L. Brant)
  • Some Applications of Risk Modeling in Breast Cancer Prevention (M. Gail)
Mixed Data Analysis
  • Joint Analysis of Mixed Outcome Data: Issues and Challenges (K. Chough)
  • Hierarchical Modeling of Endpoints of Different Types with Generalized Linear Mixed Models (C. Faes)
  • Updating the Probability of Success of Clinical Development Programs Over Time (M. Abt, P. Jordan)
Young Statisticians
  • Efficient Data-Augmented MCMC Methods for Binomial Logit Models (A. Fussl, S. Frühwirth-Schnatter, R. Frühwirth)
  • Problems of INLA in Generalized Linear Mixed Models for Binary Responses (R. Sauter, L. Held)
  • Analysis of Association on Non-Product Spaces (A. Klimova)
  • Statistical Methods for Improvement of Motif Finding Algorithms (Ž Stepančič)
  • Overrunning Data Methods: Comparisons Based on Real Data Trials (N. Soriani, I. Baldi, D. Gregori)
Statistical Methods in Genetic Epidemiology
  • Max-test to Evaluate Genetic Association Studies for Continuous and Time-to-Event Traits (L. Hothorn, E. Herberich)
  • Using Weighted Genetic Predisposition Scores to Evaluate Gene-Environment Interaction Effects on Lipid Levels (C. Lamina, L. Forer, S. Schönherr, B. Kollerits, J. Ried, C. Gieger, A. Peters, H.E. Wichmann, F. Kronenberg)
  • Using the LASSO and Ridge Regression in Case-Control Studies with Zero-Inflated Predictors (M. Kohl, G. Heinze)
Statistical Methods in Infectious Disease Epidemiology
  • Estimating MMR Vaccine Coverage from Australian Sero-Surveillance Data (N. Hens, J. Wood, N. Goeyvaerts)
  • Recent Development in Identifying Transmission Routes of Healthcare Associated Infections using Whole Genome Sequence Data (T. Kypraios)
  • Sample Size Calculations and the Temporal Dependency between an Infection and its Sequela in Randomised Controlled Trials (S. Herzog, A. Berghold)
  • Modelling Power-Law Spread in Infectious Diseases (S. Meyer, L. Held)
Statistical Evaluation of Biomarkers and Clinical Tools
  • Development in Prostate Cancer Risk Predition Tools in Response to Changes in Clinical Landscape (D. Ankerst)
  • Comparison and Evaluation of Cardiac Biomarkers in Patients with Intermittent Claudication: Results from the CAVASIC Study (B. Kollerits, G. Sturm, C. Lamina, A. Hammerer-Lercher, B. Rantner, M. Stadler, T. Ziera, J. Struck, P. Klein-Weigel, G. Fraedrich, F. Kronenberg)
  • Stopping Rules for Sequential Trials in High-Dimensional Data (S. Zehetmayer, M. Posch, A. Graf)
Biometrics – From Bench to Trials
  • A Novel Method to Estimate the Minimum Effective Dose for Monotone and Non-Monotone Dose-Response Relationships (M.J. Wolfsegger, G. Gutjahr, W. Engl, T. Jaki)
  • Nonparametric Multivariate Density Estimation Using Mixtures (X. Wang, Y. Wang)
  • How Often are you Hit by an Infection? – A Likelihood Approach to Determine the Multiplicity of Infection (K. Schneider)
Please download all available slides here:   PDF 
Opens in a new window.

Lectures not listed here but in the programme are not available for download.
If your presentation should or should not be listed there, please contact us.